The biological impact of estrogens on gender differences in congestive heart failure

Cardiovascular Research

Volumn 67, Issue 4, 2005, Pages 573-574

  Schönfelder, Gilbert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; HEART VENTRICLE HYPERTROPHY; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MEDICAL LITERATURE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGED; CARDIOVASCULAR SYSTEM; DIMERIZATION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RECEPTORS, ESTROGEN;

EID: 22744445985     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.06.017     Document Type: Editorial

References (15)

1. D.H. Silber Heart failure in women Curr Womens Health Rep 3 2003 104 109
2. E. Barrett-Connor, and D. Grady Hormone replacement therapy, heart disease, and other considerations Annu Rev Public Health 19 1998 55 72
3. M.E. Mendelsohn, and R.H. Karas The protective effects of estrogen on the cardiovascular system N Engl J Med 340 1999 1801 1811
4. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, and B. Riggs Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613
5. S.B. Hulley, and D. Grady The WHI estrogen-alone trial-do things look any better? JAMA 291 2004 1769 1771
6. M. van Eickels, C. Grohe, J.P. Cleutjens, B.J. Janssen, H.J. Wellens, and P.A. Doevendans 17beta-estradiol attenuates the development of pressure-overload hypertrophy Circulation 104 2001 1419 1423
7. C.J. Gruber, D.M. Gruber, I.M. Gruber, F. Wieser, and J.C. Huber Anatomy of the estrogen response element Trends Endocrinol Metab 15 2004 73 78
8. S. Nuedling, S. Kahlert, K. Loebbert, P.A. Doevendans, R. Meyer, and H. Vetter 17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in vitro and in vivo Cardiovasc Res 43 1999 666 674
9. J. Nordmeyer, S. Eder, S. Mahmoodzadeh, P. Martus, J. Fielitz, and J. Bass Upregulation of myocardial estrogen receptors in human aortic stenosis Circulation 110 2004 3270 3275
10. J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in proinflammatory cytokine activity after menopause Endocr Rev 23 2002 90 119
11. M.E. Mendelsohn Mechanisms of estrogen action in the cardiovascular system J Steroid Biochem Mol Biol 74 2000 337 343
12. M.K. Lindberg, S. Moverare, S. Skrtic, H. Gao, K. Dahlman-Wright, and J.A. Gustafsson Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice Mol Endocrinol 17 2003 203 208
13. S.A. Gabel, V.R. Walker, R.E. London, C. Steenbergen, K.S. Korach, and E. Murphy Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury J Mol Cell Cardiol 38 2005 289 297
14. T. Pelzer, V. Jazbutyte, K. Hu, S. Segerer, M. Nahrendorf, and P. Nordbeck The estrogen receptor-α agonist 16α-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats Cardiovasc Res 67 2005 604 612
15. T. Pelzer, P.A. Loza, K. Hu, B. Bayer, C. Dienesch, and L. Calvillo Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction Circulation 111 2005 1492 1498